ITLN1 and abnormal glucose tolerance: Thus, the research hypothesis that patients with central obesity of various degrees correlated with abnormal glucose tolerance, compared to obese subjects with normal tissue insulin sensitivity, will have lower serum concentrations of omentin was established.